Viral vectors are what we do

 
 
hero-banner-img-2.jpg
 
 
 
viral vectors, gamma-retro virus, lentivirus, AAV, CAR T-cells, T regs, mesenchymal stem cell, macrophages, NK cells, gamma delta T cells, dendritic cells, GMP, clean rooms, MHRA licensed facility, lenti, suspension cells, stable cell lines, produce…
 

From design to objective de-risking to delivery of GMP lentiviral and retroviral vectors for clinical trials, we are a CDMO that powers your innovation on the journey from lab to life

 
 
 

ViroCell Biologics is an innovation-driven lentiviral and retroviral vector CDMO focused exclusively on the design, optimization and GMP manufacturing of lentiviral and retroviral vectors to enable novel cell and gene therapies to enter clinical trials.

Unlike other viral vector CDMOs, our focus is on the intricacies of the design and on the advantages of de-risking during early-stage viral vector development. With viral vector design at the forefront of our programs, we are able to engineer complex viral vectors with key performance and / or safety attributes and improved yields. Our Innovation Research team is committed to developing better more intelligent vectors that push science forward.

By leveraging our team’s 25+ years of experience designing and developing ~200 of the market’s most complex lentiviral and retroviral vectors, Team ViroCell is driven to accelerate the development of much-needed therapies so that disease can diminish and progress can prevail. 

 
 

Our lentiviral and retroviral vector CDMO services

 

Innovation Research

Our innovation research team is passionately focused on developing new manufacturing technologies and more effective and safer lentiviral and retroviral vectors.

Learn more.

Viral Vector Design & Optimization

Our vector backbone portfolio enables us to design and manufacture multiple lentiviral or retroviral vector candidates to refine performance evaluation.

Learn more.

Viral Vector Process Development

Our process development team is driven to deliver significant improvements in critical lentiviral and retroviral vector yields.

Learn more.

GMP Lentiviral & Retroviral Vector Manufacturing

Our streamlined platform process helps us accelerate the delivery of GMP manufactured lentiviral vectors in just six months.

Learn more.

If you’re looking for a viral vector CDMO, we’d love to talk


 
We’ve designed a plug-and-play approach so that we can deliver a vector to clients within six months of starting their manufacturing campaign.
— JOHN W. HADDEN II, CHIEF EXECUTIVE OFFICER
 
 

 
 
 

Meet Team ViroCell and see what sets us apart

ViroCell is a different kind of lentiviral and retroviral vector CDMO

We are experienced, innovative, and driven by passion

Team ViroCell’s collective brain power is the force behind everything we do

Our high degree of collaboration and talent is something we call Team Intelligence™ 

 
Video Screen Shot_John_Farzin in hallway 2500x1406.png
The level of passion, commitment and just brute intelligence that this organization has, it’s like nothing I’ve experienced before.
— DAVID ENLOE, NON-EXECUTIVE DIRECTOR, VIROCELL BIOLOGICS
 

Science opens the door

People take you through

 
 
ViroCell_1308_EditBlues 2500x1000.jpg
 

What makes us different from other lentiviral and retroviral CDMOs is our people. Driven by passion and powered by science, we pride ourselves on being human, unrelenting, and highly customer focused. We are guided by the unwavering belief that we can make a difference in patients’ lives.

 

We can rapidly generate multiple versions of a particular vector to de-risk the project before it gets into the clinic.
— FARZIN FARZANEH, PhD, CHIEF SCIENTIFIC OFFICER

 VIROCELL IS PROUD TO BE WORKING IN PARTNERSHIP WITH